Literature DB >> 10091939

Expression and function of the high affinity alphaIIbbeta3 integrin in murine melanoma cells.

J Timar1, M Trikha, K Szekeres, R Bazaz, K Honn.   

Abstract

In resting platelets integrin alphaIIbbeta3 is constitutively expressed in an inactive state and it does not recognize soluble proteins. Platelet activation results in a conformational change of the low-affinity alphaIIbbeta3 to a high-affinity state which then recognizes plasma fibrinogen. The ectopic expression of alphaIIbbeta3 integrin in rodent and human cells derived from solid tumors is well documented, although little is known about its affinity state in these tumor cells. In this study we analysed expression and function of high-affinity alphaIIbbeta3 in murine metastatic melanoma B16a cells by using a mAb that specifically recognizes high-affinity alphaIIbbeta3 (PAC-1). These tumor cells while in suspension bound PAC-1 and fibrinogen. Immunofluorescent studies of B16a cells indicated that high-affinity alphaIIbbeta3 is associated with the Golgi complex and the cell surface. Stimulation of B16a cells with a PKC-activator, 12(S)-HETE, induced translocation of the high-affinity integrin from an intracellular pool to the plasma membrane, which resulted in increased tumor cell adhesion to fibronectin. In addition to participating in 12(S)-HETE-stimulated adhesion of B16a cells, the high-affinity alphaIIbbeta3 integrin is also involved in tumor cell invasion through a reconstituted basement membrane. In conclusion, results from this study suggest that in non-megakaryocytic lineage B16a cells alphaIIbbeta3 is constitutively expressed in a high-affinity state, and that this conformation participates in tumor cell adhesion and invasion.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10091939     DOI: 10.1023/a:1006533508560

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  27 in total

Review 1.  Integrins.

Authors:  E Ruoslahti
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

2.  Breaking the integrin hinge. A defined structural constraint regulates integrin signaling.

Authors:  P E Hughes; F Diaz-Gonzalez; L Leong; C Wu; J A McDonald; S J Shattil; M H Ginsberg
Journal:  J Biol Chem       Date:  1996-03-22       Impact factor: 5.157

Review 3.  Integrins: emerging paradigms of signal transduction.

Authors:  M A Schwartz; M D Schaller; M H Ginsberg
Journal:  Annu Rev Cell Dev Biol       Date:  1995       Impact factor: 13.827

4.  Critical residues of integrin alphaIIb subunit for binding of alphaIIbbeta3 (glycoprotein IIb-IIIa) to fibrinogen and ligand-mimetic antibodies (PAC-1, OP-G2, and LJ-CP3).

Authors:  T Kamata; A Irie; M Tokuhira; Y Takada
Journal:  J Biol Chem       Date:  1996-08-02       Impact factor: 5.157

5.  Activation status and function of the VLA-4 (alpha4beta1) integrin expressed on human melanoma cell lines.

Authors:  A Saini; Z Seller; D Davies; J F Marshall; I R Hart
Journal:  Int J Cancer       Date:  1997-10-09       Impact factor: 7.396

Review 6.  The structure and function of platelet integrins.

Authors:  L V Parise
Journal:  Curr Opin Cell Biol       Date:  1989-10       Impact factor: 8.382

7.  Human prostate carcinoma cells express functional alphaIIb(beta)3 integrin.

Authors:  M Trikha; J Timar; S K Lundy; K Szekeres; K Tang; D Grignon; A T Porter; K V Honn
Journal:  Cancer Res       Date:  1996-11-01       Impact factor: 12.701

Review 8.  Clues for understanding the structure and function of a prototypic human integrin: the platelet glycoprotein IIb/IIIa complex.

Authors:  J J Calvete
Journal:  Thromb Haemost       Date:  1994-07       Impact factor: 5.249

9.  VLA-4 integrin on sarcoma cell lines recognizes endothelial VCAM-1. Differential regulation of the VLA-4 avidity on various sarcoma cell lines.

Authors:  P Mattila; M L Majuri; R Renkonen
Journal:  Int J Cancer       Date:  1992-12-02       Impact factor: 7.396

10.  Characterization of tumor-induced platelet aggregation: the role of immunorelated GPIb and GPIIb/IIIa expression by MCF-7 breast cancer cells.

Authors:  L Oleksowicz; Z Mrowiec; E Schwartz; M Khorshidi; J P Dutcher; E Puszkin
Journal:  Thromb Res       Date:  1995-08-01       Impact factor: 3.944

View more
  7 in total

1.  Platelet microparticles infiltrating solid tumors transfer miRNAs that suppress tumor growth.

Authors:  James V Michael; Jeremy G T Wurtzel; Guang Fen Mao; A Koneti Rao; Mikhail A Kolpakov; Abdelkarim Sabri; Nicholas E Hoffman; Sudarsan Rajan; Dhanendra Tomar; Muniswamy Madesh; Marvin T Nieman; Johnny Yu; Leonard C Edelstein; Jesse W Rowley; Andrew S Weyrich; Lawrence E Goldfinger
Journal:  Blood       Date:  2017-05-12       Impact factor: 22.113

2.  Soluble fibrin augments platelet/tumor cell adherence in vitro and in vivo, and enhances experimental metastasis.

Authors:  J P Biggerstaff; N Seth; A Amirkhosravi; M Amaya; S Fogarty; T V Meyer; F Siddiqui; J L Francis
Journal:  Clin Exp Metastasis       Date:  1999       Impact factor: 5.150

3.  Ligand-mimetic anti-alphaIIb beta3 antibody PAC-1 inhibits tyrosine signaling, proliferation and lung colonization of melanoma cells.

Authors:  Erzsébet Rásó; József Tóvári; Andrea Ladányi; Norbert Varga; József Tímár
Journal:  Pathol Oncol Res       Date:  2005-12-31       Impact factor: 3.201

Review 4.  Complexity of signal transduction mediated by ErbB2: clues to the potential of receptor-targeted cancer therapy.

Authors:  P Nagy; A Jenei; S Damjanovich; T M Jovin; J Szölôsi
Journal:  Pathol Oncol Res       Date:  1999       Impact factor: 3.201

Review 5.  Platelets and cancer: a casual or causal relationship: revisited.

Authors:  David G Menter; Stephanie C Tucker; Scott Kopetz; Anil K Sood; John D Crissman; Kenneth V Honn
Journal:  Cancer Metastasis Rev       Date:  2014-03       Impact factor: 9.264

Review 6.  Platelet Integrins in Tumor Metastasis: Do They Represent a Therapeutic Target?

Authors:  Marion Lavergne; Emily Janus-Bell; Mathieu Schaff; Christian Gachet; Pierre H Mangin
Journal:  Cancers (Basel)       Date:  2017-09-28       Impact factor: 6.639

7.  Perspectives of Phage-Eukaryotic Cell Interactions to Control Epstein-Barr Virus Infections.

Authors:  Andrzej Górski; Ryszard Międzybrodzki; Ewa Jończyk-Matysiak; Beata Weber-Dąbrowska; Natalia Bagińska; Jan Borysowski
Journal:  Front Microbiol       Date:  2018-04-03       Impact factor: 5.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.